Drug Search Results
More Filters [+]

Rimonabant

Alternative Names: rimonabant, sr141716
Latest Update: 2023-12-11
Latest Update Note: News Article

Product Description

Mechanisms of Action: CB1 Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Colombia | European Medicines Agency | Germany | Hungary | India | Ireland | Italy | Peru | Portugal | Slovenia | Sweden | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rimonabant

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Insulin Resistance|Other|Dyslipidemia|Overweight|Diabetes, Gestational|Obesity, Abdominal|Atherosclerosis|Alcoholism|Obesity|Cocaine-Related Disorders|Healthy Volunteers|Inflammation

Phase 3: Carotid Stenosis|Arteriosclerosis|Obesity|Metabolic Syndrome X|Dyslipidemia|Atherosclerosis|Tobacco Use Disorder|Overweight|Smoking Cessation|Type 2 Diabetes|Non-alcoholic Fatty Liver Disease|Fatty Liver, Alcoholic|Weight Loss|Prader-Willi Syndrome|Weight Gain|Myocardial Ischemia|Prediabetic State|Glucose Intolerance|Spinal Cord Injuries|Coronary Artery Disease|Albuminuria|Obesity, Abdominal|Myocardial Infarction|Hepatitis, Alcoholic|Schizophrenia|Stroke|Other|Non-alcoholic Steatohepatitis

Phase 2: Spinal Cord Injuries|Obesity|Polycystic Ovary Syndrome|Alcoholic Intoxication|Affective Disorders, Psychotic|Schizophrenia|Tobacco Use Disorder|Marijuana Abuse|Hypertension|Psychotic Disorders

Phase 1: Marijuana Abuse

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2022-001522-30

P3

Active, not recruiting

Spinal Cord Injuries

2024-09-29

RIMOFATSCI-2

P2

Not yet recruiting

Spinal Cord Injuries

2023-11-01

RIMOFATSCI-1

P2

Completed

Spinal Cord Injuries

2022-06-07

Effec Acomplia gastric sensitivity

P4

Completed

Healthy Volunteers

2021-03-03

Recent News Events